Medication error rates in Iranian hospitals: a meta-analysis.


Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
17 Jun 2024
Historique:
received: 10 03 2024
accepted: 10 06 2024
medline: 18 6 2024
pubmed: 18 6 2024
entrez: 17 6 2024
Statut: epublish

Résumé

Medication errors (MEs) in hospitals decrease patient satisfaction, increase hospital mortality, lower hospital productivity, and increase in the costs of the health system. This study was conducted to determine the rate of MEs in Iranian hospitals. In this meta-analysis, all published articles on ME rates in Iranian hospitals were identified from five databases and Google Scholar and assessed for quality. The heterogeneity of the studies was examined using the I Based on the estimation of the random-effects model, the ME rate in Iranian hospitals was 10.9% (5.1%-21.7%; 95% CI). The highest rate was observed in Sanandaj in 2006 at 99.5% (92.6%-100.0%; 95% CI) and the lowest rate was observed in Kashan in 2019 at 0.2% (0.1%-0.3%; 95% CI). In addition, sample size and publication year were significantly correlated with ME rate (P < 0.05). According to the results of this study; ME rate in Iran is relatvively high based on the synthesis of the research conducted in Iranian hospitals. In addition to being costly, MEs have negative consequences for patients. Thereofore, it is necessary to emphasize the voluntary nature of medication error reporting in health sytem of Iran.

Sections du résumé

BACKGROUND AND AIM OBJECTIVE
Medication errors (MEs) in hospitals decrease patient satisfaction, increase hospital mortality, lower hospital productivity, and increase in the costs of the health system. This study was conducted to determine the rate of MEs in Iranian hospitals.
METHOD METHODS
In this meta-analysis, all published articles on ME rates in Iranian hospitals were identified from five databases and Google Scholar and assessed for quality. The heterogeneity of the studies was examined using the I
FINDINGS RESULTS
Based on the estimation of the random-effects model, the ME rate in Iranian hospitals was 10.9% (5.1%-21.7%; 95% CI). The highest rate was observed in Sanandaj in 2006 at 99.5% (92.6%-100.0%; 95% CI) and the lowest rate was observed in Kashan in 2019 at 0.2% (0.1%-0.3%; 95% CI). In addition, sample size and publication year were significantly correlated with ME rate (P < 0.05).
CONCLUSION CONCLUSIONS
According to the results of this study; ME rate in Iran is relatvively high based on the synthesis of the research conducted in Iranian hospitals. In addition to being costly, MEs have negative consequences for patients. Thereofore, it is necessary to emphasize the voluntary nature of medication error reporting in health sytem of Iran.

Identifiants

pubmed: 38886768
doi: 10.1186/s12913-024-11187-6
pii: 10.1186/s12913-024-11187-6
doi:

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

743

Informations de copyright

© 2024. The Author(s).

Références

Arch Iran Med. 2009 Mar;12(2):173-5
pubmed: 19249889
Glob J Health Sci. 2015 Dec 18;8(8):54448
pubmed: 27045413
Saf Health Work. 2018 Dec;9(4):447-453
pubmed: 30559994
Qual Saf Health Care. 2006 Feb;15(1):39-43
pubmed: 16456208
J Womens Health (Larchmt). 2005 Jan-Feb;14(1):61-7
pubmed: 15692279
Clin J Am Soc Nephrol. 2018 Nov 7;13(11):1738-1746
pubmed: 29915131
Epidemiol Health. 2017 May 17;39:e2017022
pubmed: 28774169
Aust Prescr. 2018 Jun;41(3):73-77
pubmed: 29922001
Iran J Nurs Midwifery Res. 2013 May;18(3):228-31
pubmed: 23983760
Anaesthesia. 2007 Jan;62(1):53-61
pubmed: 17156227
Int Nurs Rev. 2011 Mar;58(1):37-44
pubmed: 21281291
J Pediatr Nurs. 2004 Dec;19(6):385-92
pubmed: 15637579
J Nurs Manag. 2007 Sep;15(6):659-70
pubmed: 17688572
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
J Nurs Care Qual. 2007 Jan-Mar;22(1):28-33
pubmed: 17149082
Mayo Clin Proc. 2014 Aug;89(8):1116-25
pubmed: 24981217
PLoS One. 2015 Sep 04;10(9):e0136545
pubmed: 26340679
Am J Health Syst Pharm. 2002 Mar 1;59(5):436-46
pubmed: 11887410
Int J Qual Health Care. 2005 Feb;17(1):15-22
pubmed: 15668306
J Nurs Adm. 1999 Apr;29(4):33-8
pubmed: 10200784
Qual Saf Health Care. 2010 Oct;19(5):e7
pubmed: 20671079

Auteurs

Parvaneh Isfahani (P)

Department of Health Management, School of Public Health, Zabol University of Medical Sciences, Zabol, Iran.

Aliyeh Bazi (A)

Department of Clinical Pharmacy, School of Pharmacy, Zabol University of Medical Sciences, Zabol, Iran.

Samira Alirezaei (S)

Research Center for Social Determinants of Health, Saveh University of Medical Sciences, Saveh, Iran.

Somayeh Samani (S)

Department of Occupational Health Engineering, School of Public Health, Zabol University of Medical Sciences, Zabol, Iran.

Mohammad Sarani (M)

Department of Public Health, School of Public Health, Zabol University of Medical Sciences, Zabol, Iran.

Fatemeh Boulagh (F)

Department of Health Management, School of Public Health, Zabol University of Medical Sciences, Zabol, Iran.

Mahdieh Poodineh Moghadam (M)

Department of Nursing, School of Nursing and Midwifery, Zabol University of Medical Sciences, Zabol, Iran.

Mahnaz Afshari (M)

Research Center for Social Determinants of Health, Saveh University of Medical Sciences, Saveh, Iran. mahnazafshar89@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH